Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/6/2019 |
| Start Date: | March 2011 |
| End Date: | December 2020 |
This component of a larger Center of Research Excellence Grant improves treatment for drug
abuse by developing effective linkages between specialty drug treatment and primary health
care.
abuse by developing effective linkages between specialty drug treatment and primary health
care.
This is a longitudinal two-arm quasi-experimental 3-month alternating off/on design over a 30
month period in which, after a random start, the Linkage condition alternately is added to
Usual Care in the Chemical Dependency (CD) clinic and then removed. We compare Usual Care to
Usual Care plus Linkage. Follow-up interviews will be conducted at 6, 12 and 24 months. The
Linkage intervention includes Usual Care plus 1) sessions on activation regarding overall
health behaviors and on selecting a Primary Care physician and communicating with him/her,
and 2) a linkage phone call (and/or a facilitated email) with the patient, clinician, and
Primary Care physician. The intervention aims to place drug abuse problems in the context of
overall health and health care and to activate patients to increase involvement in their own
health care.
month period in which, after a random start, the Linkage condition alternately is added to
Usual Care in the Chemical Dependency (CD) clinic and then removed. We compare Usual Care to
Usual Care plus Linkage. Follow-up interviews will be conducted at 6, 12 and 24 months. The
Linkage intervention includes Usual Care plus 1) sessions on activation regarding overall
health behaviors and on selecting a Primary Care physician and communicating with him/her,
and 2) a linkage phone call (and/or a facilitated email) with the patient, clinician, and
Primary Care physician. The intervention aims to place drug abuse problems in the context of
overall health and health care and to activate patients to increase involvement in their own
health care.
Inclusion Criteria:
- Research participants will be adult patients at the Kaiser Permanente San Francisco
Chemical Dependency Recovery Program, who have completed 2 weeks of treatment.
Exclusion Criteria:
- Patients with a diagnosis of dementia, mental retardation, or who are actively
psychotic or suicidal will be excluded by their clinician.
We found this trial at
1
site
Click here to add this to my saved trials
